Lessons from the Trials for the Desirable Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Diabetic Cardiovascular Events and Renal Dysfunction

Recent large placebo-controlled trials of sodium glucose co-transporter 2 (SGLT2) inhibitors revealed desirable effects on heart failure (HF) and renal dysfunction; however, the mechanisms underlying these effects are unknown. The characteristic changes in the early stage of diabetic cardiomyopathy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakisaka, Masanori, Kamouchi, Masahiro, Kitazono, Takanari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888253/
https://www.ncbi.nlm.nih.gov/pubmed/31726765
http://dx.doi.org/10.3390/ijms20225668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888253/
https://www.ncbi.nlm.nih.gov/pubmed/31726765
http://dx.doi.org/10.3390/ijms20225668

Ejemplares similares